P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors

ABSTRACT: A Phase 1, open label, dose escalation and expanded cohort study of P-MUC1C-ALLO1 in adult subjects with advanced or metastatic epithelial derived solid tumors, including but not limited to the tumor types listed below.

DISEASE(S): Nasopharyngeal Carcinoma,Carcinoma,Colorectal Cancer,Non Small Cell Lung Cancer,Pancreatic Cancer,Nasopharyngeal Cancer,Breast Cancer,Ovarian Cancer,Squamous Cell Carcinoma Of Head And Neck,Gastric Cancer,Carcinoma, Renal Cell,Renal Cell Carcinoma,Nasopharyngeal Neoplasms,Head And Neck Squamous Cell Carcinoma

PROVIDER: 2404627 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR